Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Cancer Res ; 80(18): 3906-3919, 2020 09 15.
Artículo en Inglés | MEDLINE | ID: mdl-32699136

RESUMEN

Extracellular ATP (eATP) is a signaling molecule that variably affects all cells of the immune system either directly or after hydrolysis to adenosine. Although eATP is virtually absent in the interstitium of normal tissues, it can be present in the hundreds of micromolar range in tumors, a concentration compatible with activation of the ATP-gated ionotropic P2X7 receptor. Here, we show that P2X7 activity in tumor-infiltrating lymphocytes (TIL) induces cellular senescence and limits tumor suppression. P2X7 stimulation affected cell cycling of effector T cells and resulted in generation of mitochondrial reactive oxygen species and p38 MAPK-dependent upregulation of cyclin-dependent kinase inhibitor 1A (Cdkn1a, encoding for p21Waf1/Cip1). Lack of P2X7 promoted a transcriptional signature that correlated with enhanced cytotoxic T-cell response in human solid tumors. In mice, transfer of tumor-specific T cells with deletion of P2rx7 significantly reduced tumor growth and extended survival. Collectively, these findings uncover a purinergic checkpoint that can be targeted to improve the efficacy of cancer immunotherapy strategies. SIGNIFICANCE: These findings suggest that the purinergic checkpoint P2X7 may be targeted to enhance T-cell-mediated cancer immunotherapy and improve T effector cell accumulation in the tumor microenvironment. GRAPHICAL ABSTRACT: http://cancerres.aacrjournals.org/content/canres/80/18/3906/F1.large.jpg.


Asunto(s)
Inhibición de Migración Celular , Senescencia Celular/inmunología , Linfocitos Infiltrantes de Tumor/inmunología , Linfocitos Infiltrantes de Tumor/metabolismo , Melanoma Experimental/inmunología , Receptores Purinérgicos P2X7/metabolismo , Adenosina Trifosfato/metabolismo , Animales , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD8-positivos/inmunología , Ciclo Celular , Línea Celular Tumoral , Inhibidor p21 de las Quinasas Dependientes de la Ciclina/metabolismo , Citometría de Flujo/métodos , Perfilación de la Expresión Génica , Humanos , Inhibidores de Puntos de Control Inmunológico/uso terapéutico , Inmunoterapia Adoptiva/métodos , Melanoma Experimental/patología , Melanoma Experimental/terapia , Ratones , Ratones Endogámicos C57BL , Mitocondrias/metabolismo , Trasplante de Neoplasias , Antagonistas del Receptor Purinérgico P2X , Especies Reactivas de Oxígeno/metabolismo , Receptores Purinérgicos P2X7/deficiencia , Linfocitos T Citotóxicos/inmunología , Transcripción Genética , Microambiente Tumoral/inmunología , Regulación hacia Arriba
2.
J Exp Med ; 216(2): 317-336, 2019 02 04.
Artículo en Inglés | MEDLINE | ID: mdl-30655308

RESUMEN

Altered control of T follicular helper (Tfh) cells can lead to generation of autoantibodies and autoimmune manifestations. Signaling pathways that selectively limit pathogenic responses without affecting the protective function of Tfh cells are unknown. Here we show that the ATP-gated ionotropic P2X7 receptor restricts the expansion of aberrant Tfh cells and the generation of self-reactive antibodies in experimental murine lupus, but its activity is dispensable for the expansion of antigen-specific Tfh cells during vaccination. P2X7 stimulation promotes caspase-mediated pyroptosis of Tfh cells and controls the development of pathogenic ICOS+ IFN-γ-secreting cells. Circulating Tfh cells from patients with systemic lupus erythematosus (SLE) but not primary antiphospholipid syndrome (PAPS), a nonlupus systemic autoimmune disease, were hyporesponsive to P2X7 stimulation and resistant to P2X7-mediated inhibition of cytokine-driven expansion. These data point to the P2X7 receptor as a checkpoint regulator of Tfh cells; thus, restoring P2X7 activity in SLE patients could selectively limit the progressive amplification of pathogenic autoantibodies, which deteriorate patients' conditions.


Asunto(s)
Lupus Eritematoso Sistémico/inmunología , Receptores Purinérgicos P2X7/inmunología , Linfocitos T Colaboradores-Inductores/inmunología , Animales , Autoanticuerpos/genética , Autoanticuerpos/inmunología , Modelos Animales de Enfermedad , Interferón gamma/genética , Interferón gamma/inmunología , Lupus Eritematoso Sistémico/genética , Lupus Eritematoso Sistémico/patología , Ratones , Ratones Noqueados , Piroptosis/genética , Piroptosis/inmunología , Receptores Purinérgicos P2X7/genética , Linfocitos T Colaboradores-Inductores/patología
3.
Nat Commun ; 8(1): 1917, 2017 12 04.
Artículo en Inglés | MEDLINE | ID: mdl-29203869

RESUMEN

The melastatin-like transient-receptor-potential-7 protein (TRPM7), harbouring a cation channel and a serine/threonine kinase, has been implicated in thymopoiesis and cytokine expression. Here we show, by analysing TRPM7 kinase-dead mutant (Trpm7 R/R ) mice, that the enzymatic activity of the receptor is not essential for thymopoiesis, but is required for CD103 transcription and gut-homing of intra-epithelial lymphocytes. Defective T cell gut colonization reduces MHCII expression in intestinal epithelial cells. Mechanistically, TRPM7 kinase activity controls TGF-ß-induced CD103 expression and pro-inflammatory T helper 17, but not regulatory T, cell differentiation by modulating SMAD2. Notably, we find that the TRPM7 kinase activity promotes gut colonization by alloreactive T cells in acute graft-versus-host disease. Thus, our results unravel a function of TRPM7 kinase in T cell activity and suggest a therapeutic potential of kinase inhibitors in averting acute graft-versus-host disease.


Asunto(s)
Enfermedad Injerto contra Huésped/genética , Intestinos/inmunología , Linfopoyesis/genética , Linfocitos T Reguladores/citología , Canales Catiónicos TRPM/genética , Células Th17/citología , Animales , Antígenos CD/inmunología , Diferenciación Celular/genética , Genes MHC Clase II/genética , Genes MHC Clase II/inmunología , Enfermedad Injerto contra Huésped/inmunología , Cadenas alfa de Integrinas/inmunología , Ratones , Mutación , Proteína Smad2/inmunología , Linfocitos T/citología , Linfocitos T/inmunología , Linfocitos T Reguladores/inmunología , Canales Catiónicos TRPM/inmunología , Células Th17/inmunología , Factor de Crecimiento Transformador beta/inmunología
4.
Sci Rep ; 6: 24515, 2016 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-27079797

RESUMEN

The pathogenic role of SOD1 mutations in amyotrophic lateral sclerosis (ALS) was investigated using a zebrafish disease model stably expressing the ALS-linked G93R mutation. In addition to the main pathological features of ALS shown by adult fish, we found remarkably precocious alterations in the development of motor nerve circuitry and embryo behavior, and suggest that these alterations are prompted by interneuron and motor neuron hyperexcitability triggered by anomalies in the persistent pacemaker sodium current INaP. The riluzole-induced modulation of INaP reduced spinal neuron excitability, reverted the behavioral phenotypes and improved the deficits in motor nerve circuitry development, thus shedding new light on the use of riluzole in the management of ALS. Our findings provide a valid phenotype-based tool for unbiased in vivo drug screening that can be used to develop new therapies.


Asunto(s)
Potenciales de Acción/efectos de los fármacos , Potenciales de Acción/genética , Esclerosis Amiotrófica Lateral/genética , Neuronas Motoras/efectos de los fármacos , Neuronas Motoras/fisiología , Fenilglioxal/análogos & derivados , Superóxido Dismutasa/genética , Esclerosis Amiotrófica Lateral/diagnóstico , Animales , Animales Modificados Genéticamente , Modelos Animales de Enfermedad , Expresión Génica , Locomoción , Actividad Motora/efectos de los fármacos , Músculos/patología , Mutación , Unión Neuromuscular/metabolismo , Fenotipo , Fenilglioxal/farmacología , Riluzol/farmacología , Médula Espinal/patología , Pez Cebra
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA